The balance between RANKL and OPN expression serves a key role in osteoclast differentiation and function, where dysregulation of the ratio between the two has been found in a variety of bone metabolism diseases such as postmenopausal osteoporosis [19–21]. This evidence concerns the gene SPP1 and postmenopausal osteoporosis.